MYCN and neuroblastoma: High mRNA expression of USP5 had a strong association with poor neuroblastoma patient prognosis in publicly available R2 gene expression datasets (n = 469 for Kocak dataset and n = 498 for SEQC dataset) for the MYCN-amplified patient subsets (Fig. 4a) [23].